Annual Working Capital
$284.17 M
-$169.00 M-37.29%
December 31, 2024
Summary
- As of March 12, 2025, NMRA annual working capital is $284.17 million, with the most recent change of -$169.00 million (-37.29%) on December 31, 2024.
- During the last 3 years, NMRA annual working capital has fallen by -$108.16 million (-27.57%).
- NMRA annual working capital is now -37.29% below its all-time high of $453.17 million, reached on December 31, 2023.
Performance
NMRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$284.17 M
-$32.70 M-10.32%
December 31, 2024
Summary
- As of March 12, 2025, NMRA quarterly working capital is $284.17 million, with the most recent change of -$32.70 million (-10.32%) on December 31, 2024.
- Over the past year, NMRA quarterly working capital has dropped by -$32.70 million (-10.32%).
- NMRA quarterly working capital is now -42.78% below its all-time high of $496.61 million, reached on September 30, 2023.
Performance
NMRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NMRA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -10.3% |
| 3 y3 years | -27.6% | -10.5% |
| 5 y5 years | +10000.0% | -10.5% |
NMRA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.3% | at low | -42.8% | at low |
| 5 y | 5-year | -37.3% | >+9999.0% | -42.8% | +54.0% |
| alltime | all time | -37.3% | >+9999.0% | -42.8% | +54.0% |
Neumora Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $284.17 M(-37.3%) | $284.17 M(-10.3%) |
| Sep 2024 | - | $316.87 M(-15.5%) |
| Jun 2024 | - | $375.19 M(-10.3%) |
| Mar 2024 | - | $418.18 M(-7.7%) |
| Dec 2023 | $453.17 M(+24.4%) | $453.17 M(-8.7%) |
| Sep 2023 | - | $496.61 M(+59.9%) |
| Jun 2023 | - | $310.52 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $364.26 M(-7.2%) | $364.26 M(+14.7%) |
| Jun 2022 | - | $317.53 M(-8.0%) |
| Mar 2022 | - | $345.00 M(-12.1%) |
| Dec 2021 | $392.32 M(+112.7%) | - |
| Dec 2021 | - | $392.32 M(-7.1%) |
| Sep 2021 | - | $422.13 M(+128.8%) |
| Dec 2020 | $184.47 M(<-9900.0%) | $184.47 M |
| Dec 2019 | -$21.00 K | - |
FAQ
- What is Neumora Therapeutics annual working capital?
- What is the all time high annual working capital for Neumora Therapeutics?
- What is Neumora Therapeutics annual working capital year-on-year change?
- What is Neumora Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly working capital year-on-year change?
What is Neumora Therapeutics annual working capital?
The current annual working capital of NMRA is $284.17 M
What is the all time high annual working capital for Neumora Therapeutics?
Neumora Therapeutics all-time high annual working capital is $453.17 M
What is Neumora Therapeutics annual working capital year-on-year change?
Over the past year, NMRA annual working capital has changed by -$169.00 M (-37.29%)
What is Neumora Therapeutics quarterly working capital?
The current quarterly working capital of NMRA is $284.17 M
What is the all time high quarterly working capital for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly working capital is $496.61 M
What is Neumora Therapeutics quarterly working capital year-on-year change?
Over the past year, NMRA quarterly working capital has changed by -$32.70 M (-10.32%)